BD Stock Dips: Analyst Downgrade Triggers Investor Jitters

Markets & Money Today | 2 Min News | The Daily News Now! - A podcast by The Daily News Now! - Saturdays

Try Bookbeat 60! days for free, click here

Try Bookbeat 60! days for free, click here

Enjoy a whole world of audiobooks and e-books, everything from new releases to the classics

 Sponsored

Categories:

Business

BD Stock Plummets After Neutral Analyst Rating! Despite long-term profit potential, RBC Capital's cautious outlook on BD, citing slow earnings growth and better investment options elsewhere, triggered a significant stock drop. Is this a buying opportunity or a sign of deeper troubles for the medical tech giant? Find out why BD is down 20% this year and what it means for investors. Hosted on Acast. See acast.com/privacy for more information.

Visit the podcast's native language site